Figure 3
(a) Box plots showing the infiltrating immune cells in RME and RMA tumors compared to other tumor entities. (b) Box plots of the CD3, CD68 and CD163 infiltrating cells in RMS. The boxes extend from the 25th to 75th percentile, the horizontal line in the box represents the median, for the location of the wiskers the turkey method was choosen. (c) Shows a comparision of CD68, CD163 infiltrating cells in RMA and RME tumors; single samples and the corresponding mean values are shown. (d) Shows the correlation between CD68 and CD163 cells in RMS tumors. RMA – alveolar Rhabdomyosarcoma; RME – embryonal Rhabdomyosarcoma; BLCA – bladder carcinoma; COAD – colorectal adenocarcinoma; ESCA - esophageal squamous carcinoma; HNSC - head and neck squamous cell carcinoma; LUAD - lung adenocarcinoma; LUSC - lung squamous cell carcinoma; MEL – melanoma; OV - ovarian cancer; STAD - gastric cancer; *p < 0.05, ** 0.05 > p > 0.01, *** 0.01 > p > 0.005, ****p < 0.005.
